Tag: Prescription Drugs
Psychostimulants Beneficial for Amphetamine-Type Stimulant Use Disorder
Higher doses of prescription psychostimulants, treatment duration positively linked to longer retention
Four JAK Inhibitors Have Comparable Efficacy, Safety for RA
Baseline CRP, Clinical Disease Activity Index, glucocorticoid dose predict resistance to CDAI-low disease activity achievement
Clot Risk High With Oral Contraceptives for Those at Genetic Risk
Risk highest in the first two years, regardless of genetic risk, and lower for continued use
Triptans, Ergots, Antiemetics Most Effective Meds for Migraine
Individual medications with the highest odds ratios were eletriptan, zolmitriptan, and sumatriptan
Neratinib, Fulvestrant, Trastuzumab Combo Aids Metastatic Breast Cancer
Three-drug combination beneficial for HR-positive HER2-mutant metastatic breast cancer with prior CDK4/6i therapy
Fluvoxamine Does Not Shorten Duration of COVID-19 Symptoms
Findings observed among adults with mild or moderate COVID-19
Two-Week DAA Prophylaxis Prevents Hep C After Kidney Transplant
Two-week DAA optimal for preventing infection in individuals without HCV viremia who received kidney from HCV-viremia-positive donors
Long-Term Exposure to ADHD Meds Linked to Increased Risk for CVD
4 percent increase in risk for CVD seen in association with each one-year increase in ADHD meds across 14 years of follow-up
Disease-Modifying Therapy Use for Sickle Cell Remained Low 2014 to 2021
Inconsistent users of DMT had higher prevalence of vaso-occlusive crises, splenic complications, health care visits
Ubrogepant Beneficial for Treating Migraine During the Prodrome
Absence of moderate or severe headache reported in 46 and 29 percent of prodrome events that had been treated with ubrogepant, placebo
